We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Accurate Detection of Fusion Transcripts
Product News

Accurate Detection of Fusion Transcripts

Accurate Detection of Fusion Transcripts
Product News

Accurate Detection of Fusion Transcripts


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Accurate Detection of Fusion Transcripts"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Cancer researchers now have a set of TaqMan gene expression assays designed to detect fusion transcripts using real-time PCR. Certain fusion transcripts are considered rare and are not well characterized; therefore, detecting these rare events using a single technology can deliver ambiguous results. As such, researchers often employ an orthogonal method of validation to confirm results. As a complementary solution to next-generation sequencing (NGS) panels, including the Oncomine Focus Assay, the TaqMan gene expression assays are designed to serve as an orthogonal validation method for confirming NGS results.

Advertisement